IdentificationGeneric Name(2R)-2-(3-Biphenylyl)-N-{(2R)-2-hydroxy-3-[(2-pyridinylsulfonyl)amino]propyl}-4-methylpentanamideDrugBank Accession NumberDB04244BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


3DDownload MOLSDF3D-SDFPDBSMILESInChI


 Similar StructuresStructure for (2R)-2-(3-Biphenylyl)-N-{(2R)-2-hydroxy-3-[(2-pyridinylsulfonyl)amino]propyl}-4-methylpentanamide (DB04244)× CloseWeightAverage: 481.607 Monoisotopic: 481.203527185 Chemical FormulaC26H31N3O4SSynonymsNot AvailablePharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismUCathepsin KNot AvailableHumansAbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableChemical TaxonomyProvided by ClassyfireDescriptionThis compound belongs to the class of organic compounds known as biphenyls and derivatives. These are organic compounds containing to benzene rings linked together by a C-C bond.KingdomOrganic compoundsSuper ClassBenzenoidsClassBenzene and substituted derivativesSub ClassBiphenyls and derivativesDirect ParentBiphenyls and derivativesAlternative ParentsPyridinesulfonamides / Phenylacetamides / Organosulfonamides / N-acyl amines / Heteroaromatic compounds / Aminosulfonyl compounds / Secondary carboxylic acid amides / Secondary alcohols / Azacyclic compounds / Organonitrogen compounds / Organic oxides / Hydrocarbon derivatives / Carbonyl compounds


 show 3 moreSubstituentsAlcohol / Aminosulfonyl compound / Aromatic heteromonocyclic compound / Azacycle / Biphenyl / Carbonyl group / Carboxamide group / Carboxylic acid derivative / Fatty acyl / Fatty amide / Heteroaromatic compound / Hydrocarbon derivative / N-acyl-amine / Organic nitrogen compound / Organic oxide / Organic oxygen compound / Organic sulfonic acid or derivatives / Organoheterocyclic compound / Organonitrogen compound / Organooxygen compound / Organosulfonic acid amide / Organosulfonic acid or derivatives / Organosulfur compound / Phenylacetamide / Pyridine / Pyridine-2-sulfonamide / Secondary alcohol / Secondary carboxylic acid amide / Sulfonyl


 show 19 moreMolecular FrameworkAromatic heteromonocyclic compoundsExternal DescriptorsNot AvailableAffected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeyYCDHZDINQZLSRR-DNQXCXABSA-NInChIInChI=1S/C26H31N3O4S/c1-19(2)15-24(22-12-8-11-21(16-22)20-9-4-3-5-10-20)26(31)28-17-23(30)18-29-34(32,33)25-13-6-7-14-27-25/h3-14,16,19,23-24,29-30H,15,17-18H2,1-2H3,(H,28,31)/t23-,24-/m1/s1IUPAC Name(2R)-2-{[1,1'-biphenyl]-3-yl}-N-[(2R)-2-hydroxy-3-(pyridine-2-sulfonamido)propyl]-4-methylpentanamideSMILES[H]N(C[C@@H](O)CN([H])S(=O)(=O)C1=CC=CC=N1)C(=O)[C@H](CC(C)C)C1=CC=CC(=C1)C1=CC=CC=C1ReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound5288593PubChem Substance46506469ChemSpider4450723ZINCZINC000003870500PDBe LigandI10PDB Entries1bgoClinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility0.00252 mg/mLALOGPSlogP2.81ALOGPSlogP3.77ChemaxonlogS-5.3ALOGPSpKa (Strongest Acidic)8.86ChemaxonpKa (Strongest Basic)-0.73ChemaxonPhysiological Charge0ChemaxonHydrogen Acceptor Count5ChemaxonHydrogen Donor Count3ChemaxonPolar Surface Area108.39 Å2ChemaxonRotatable Bond Count10ChemaxonRefractivity132.81 m3·mol-1ChemaxonPolarizability52.53 Å3ChemaxonNumber of Rings3ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterNoChemaxonVeber's RuleNoChemaxonMDDR-like RuleYesChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption+0.9471Blood Brain Barrier-0.6459Caco-2 permeable-0.6724P-glycoprotein substrateSubstrate0.5P-glycoprotein inhibitor INon-inhibitor0.5334P-glycoprotein inhibitor IINon-inhibitor0.8792Renal organic cation transporterNon-inhibitor0.9353CYP450 2C9 substrateNon-substrate0.7419CYP450 2D6 substrateNon-substrate0.8049CYP450 3A4 substrateNon-substrate0.5771CYP450 1A2 substrateNon-inhibitor0.8717CYP450 2C9 inhibitorNon-inhibitor0.6566CYP450 2D6 inhibitorNon-inhibitor0.8749CYP450 2C19 inhibitorNon-inhibitor0.6275CYP450 3A4 inhibitorNon-inhibitor0.6154CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.7382Ames testNon AMES toxic0.682CarcinogenicityNon-carcinogens0.5806BiodegradationNot ready biodegradable0.9932Rat acute toxicity2.4446 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.9927hERG inhibition (predictor II)Non-inhibitor0.6826  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn more


 Details1. Cathepsin KKindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionProteoglycan bindingSpecific FunctionClosely involved in osteoclastic bone resorption and may participate partially in the disorder of bone remodeling. Displays potent endoprotease activity against fibrinogen at acid pH. May play an i...Gene NameCTSKUniprot IDP43235Uniprot NameCathepsin KMolecular Weight36965.82 DaReferencesOverington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article] Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article] Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52 